/ /

  • linkedin
  • Increase Font
  • Sharebar

    Shire's FDA-approved drug ends dry eye treatment drought

    Editor's Update: Within weeks of its FDA approval, Shire's dry eye drug (Xiidra) is now available by prescription. With the availability of the drug, Shire has patient-focused resources to share information about prescription coverage and savings (subject to eligibility): 

    • ask iiris, a phone service offering live-person responses to questions regarding information about insurance coverage, benefits, co-pays and availability in pharmacies. To ask iiris, please call 1-844-my-iiris.

    • Xiidra iinsider, an optional program that patients can sign up for to receive information and special offers, either via text or email.

    Ophthalmologists have been waiting more than a decade for a new treatment option for their dry eye patients—and the anticipation is finally over. 

    Lifitegrast ophthalmic solution 5% (Xiidra, Shire Ophthalmics) is a twice-daily eye drop solution and is the only FDA-approved drug indicated to treat the signs and symptoms of dry eye disease, according to the company. 

    More: Shire's Robert Dempsey talks about company's mission, pipeline

    Signs of dry eye include inferior corneal staining which can be observed via slit lamp, whereas symptoms refer to the patient-reported discomfort associated with the disease. The symptoms are typically what drive patients to see an ophthalmologist in the first place.

    Recent: What books are your fellow ophthalmologists reading?

    Shire expects to launch the drug in the United States in the third quarter of 2016.

    The last dry eye drug approval was for cyclosporine ophthalmic emulsion 0.05% (Restasis, Allergan) in 2003. However, cyclosporine functions to increase patients’ tear production, and did not have a specific indication for treating the signs and symptoms of dry eye, according to the FDA.

    Lifitegrast is intended to help treat the estimated 16 million adults in the United States who have been diagnosed with dry eye. The chronic disease can eventually lead to eye surface damage and loss of visual function.

    Learn more about the drug here.

    Reaching both sides of the aisle

    Jolie Higazi
    Jolie is the Content Specialist for Ophthalmology Times. She can be reached at [email protected]

    New Call-to-action

    2 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • sayantani@------.com
      It sounds like a great news for potential dry eye patients. Its great that contact lenses are now better than what they used to be . You can shop them at gkb opticals
    • Anonymous
      It sounds like a great news for potential dry eye patients. Its great that contact lenses are now better than what they used to be . You can shop them at gkb opticals

    Poll

    View Results